Baillie Gifford & Co’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-192
Closed -$4K – 497
2021
Q4
$4K Hold
192
– – ﹤0.01% 488
2021
Q3
$6K Hold
192
– – ﹤0.01% 473
2021
Q2
$5K Hold
192
– – ﹤0.01% 461
2021
Q1
$4K Buy
192
+37
+24% +$757 ﹤0.01% 437
2020
Q4
$3K Buy
+155
New +$2.84K ﹤0.01% 421

Other funds holding ALKS

Baillie Gifford & Co's ALKS Position: Q1 2022 in Review

Baillie Gifford & Co sold out of Alkermes (ALKS) in Q1 2022, closing a stake of 192 shares — an estimated $4K sold.

Baillie Gifford & Co first reported a position in ALKS in Q4 2020 and held it in 5 quarters. The position peaked at $6K in Q3 2021. 247 funds tracked by Wall St. Rank hold ALKS as of Q1 2022.

  • Baillie Gifford & Co reported no remaining Alkermes position as of Q1 2022 after selling out during the quarter.
  • Baillie Gifford & Co sold 192 Alkermes shares in Q1 2022, an estimated $4K.
  • Baillie Gifford & Co first reported a position in Alkermes in Q4 2020 and held it in 5 quarters.
  • Baillie Gifford & Co's Alkermes position peaked at $6K in Q3 2021.
  • 247 funds tracked by Wall St. Rank held Alkermes as of Q1 2022.

Based on Baillie Gifford & Co's 13F filing for Q1 2022, filed 5 May 2022.